Effects of chemopreventive agents on the incidence of recurrent colorectal adenomas: a systematic review with network meta-analysis of randomized controlled trials

References

• FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
   PubMed Web of Science ®Google Scholar
• ArnoldMSierraMSLaversanneMSoerjomataramIJemalABrayFGlobal patterns and trends in colorectal cancer incidence and mortalityGut201766468369126818619
   PubMed Web of Science ®Google Scholar
• VeettilSKLimKGChaiyakunaprukNChingSMHassanMRAColorectal cancer in Malaysia: its burden and implications for a multiethnic countryAsian J Surg Epub201681
   PubMedGoogle Scholar
• SiegelRDeSantisCJemalAColorectal cancer statistics, 2014CA Cancer J Clin201464210411724639052
   PubMed Web of Science ®Google Scholar
• U.S. Preventive Services Task ForceRoutine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statementAnn Intern Med2007146536136417339621
   PubMed Web of Science ®Google Scholar
• LevinBPotential pitfalls in the use of surrogate endpoints in colorectal adenoma chemopreventionJ Natl Cancer Inst2003951069769912759378
   PubMedGoogle Scholar
• YamajiYMitsushimaTIkumaHIncidence and recurrence rates of colorectal adenomas estimated by annually repeated colonoscopies on asymptomatic JapaneseGut200453456857215016753
   PubMedGoogle Scholar
• LevinBLiebermanDAMcFarlandBScreening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of RadiologyCA Cancer J Clin200858313016018322143
   PubMed Web of Science ®Google Scholar
• CDC [webpage on the Internet]Colorectal Cancer Screening Rates Remain LowThe Centers for Disease Control and Prevention (CDC)2013 Available from: http://www.cdc.gov/media/releases/2013/p1105-colorectal-cancer-screening.htmlAccessed December 15, 2016
   Google Scholar
• Bonithon-KoppCPiardFFengerCColorectal adenoma characteristics as predictors of recurrenceDis Colon Rectum200447332333314991494
   PubMedGoogle Scholar
• CottetVJoosteVFournelIBouvierA-MFaivreJBonithon-KoppCLong-term risk of colorectal cancer after adenoma removal: a population-based cohort studyGut20126181180118622110052
   PubMed Web of Science ®Google Scholar
• StrumWBColorectal adenomasN Engl J Med2016374111065107526981936
   PubMed Web of Science ®Google Scholar
• WangDDuBoisRNThe role of COX-2 in intestinal inflammation and colorectal cancerOncogene201029678178819946329
   PubMed Web of Science ®Google Scholar
• BaronJAColeBFSandlerRSA randomized trial of aspirin to prevent colorectal adenomasN Engl J Med20033481089189912621133
   PubMed Web of Science ®Google Scholar
• BenamouzigRDeyraJMartinADaily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trialGastroenterology2003125232833612891533
   PubMed Web of Science ®Google Scholar
• BenamouzigRUzzanBDeyraJPrevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trialGut201261225526121890814
   PubMedGoogle Scholar
• IshikawaHMutohMSuzukiSThe preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients: a randomised trialGut201463111755175924488498
   PubMed Web of Science ®Google Scholar
• LoganRFAGraingeMJShepherdVCArmitageNCMuirKRukCAP Trial GroupAspirin and folic acid for the prevention of recurrent colorectal adenomasGastroenterology20081341293818022173
   PubMed Web of Science ®Google Scholar
• SandlerRSHalabiSBaronJAA randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancerN Engl J Med20033481088389012621132
   PubMed Web of Science ®Google Scholar
• ArberNEagleCJSpicakJCelecoxib for the prevention of colorectal adenomatous polypsN Engl J Med2006355988589516943401
   PubMed Web of Science ®Google Scholar
• BertagnolliMMEagleCJZauberAGCelecoxib for the prevention of sporadic colorectal adenomasN Engl J Med2006355987388416943400
   PubMed Web of Science ®Google Scholar
• BaronJASandlerRSBresalierRSA randomized trial of rofecoxib for the chemoprevention of colorectal adenomasGastroenterology200613161674168217087947
   PubMed Web of Science ®Google Scholar
• LadenheimJGarciaGTitzerDEffect of sulindac on sporadic colonic polypsGastroenterology19951084108310877698575
   PubMedGoogle Scholar
• MeyskensFLMcLarenCEPelotDDifluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trialCancer Prev Res (Phila)200811323818841250
   PubMed Web of Science ®Google Scholar
• TakayamaTNagashimaHMaedaMRandomized double-blind trial of sulindac and etodolac to eradicate aberrant crypt foci and to prevent sporadic colorectal polypsClin Cancer Res201117113803381121385928
   PubMedGoogle Scholar
• BaronJABeachMMandelJSCalcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study GroupN Engl J Med199934021011079887161
   PubMed Web of Science ®Google Scholar
• HofstadBAlmendingenKVatnMGrowth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidantsDigestion19985921481569586828
   PubMed Web of Science ®Google Scholar
• BaronJABarryELMottLAA trial of calcium and vitamin D for the prevention of colorectal adenomasN Engl J Med2015373161519153026465985
   PubMed Web of Science ®Google Scholar
• ChuDZJHusseyMAAlbertsDSColorectal Chemoprevention Pilot Study (SWOG-9041), randomized and placebo controlled: the importance of multiple luminal lesionsClin Colorectal Cancer201110431031621782524
   PubMedGoogle Scholar
• ColeBFBaronJASandlerRSFolic acid for the prevention of colorectal adenomas: a randomized clinical trialJAMA2007297212351235917551129
   PubMed Web of Science ®Google Scholar
• MacLennanRMacraeFBainCRandomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomasJ Natl Cancer Inst19958723176017667473832
   PubMedGoogle Scholar
• BonelliLPuntoniMGatteschiBAntioxidant supplement and long-term reduction of recurrent adenomas of the large bowel. A double-blind randomized trialJ Gastroenterol201348669870523065023
   PubMed Web of Science ®Google Scholar
• WuKPlatzEAWillettWCA randomized trial on folic acid supplementation and risk of recurrent colorectal adenomaAm J Clin Nutr20099061623163119864409
   PubMed Web of Science ®Google Scholar
• GreenbergERBaronJATostesonTDA clinical trial of anti-oxidant vitamins to prevent colorectal adenomaN Engl J Med199433131411478008027
   PubMedGoogle Scholar
• McKeown-EyssenGHollowayCJazmajiVBright-SeeEDionPBruceWRA randomized trial of vitamins C and E in the prevention of recurrence of colorectal polypsCancer Res19884816470147053293777
   PubMed Web of Science ®Google Scholar
• Ponz de LeonMRoncucciLChemoprevention of colorectal tumors: role of lactulose and of other agentsScand J Gastroenterol Suppl199722272759145453
   PubMedGoogle Scholar
• Gomez CerezoJLubomirov HristovRCarcas SansuánAJVázquez RodríguezJJOutcome trials of COX-2 selective inhibitors: global safety evaluation does not promise benefitsEur J Clin Pharmacol200359216917512698301
   PubMedGoogle Scholar
• JüniPNarteyLReichenbachSSterchiRDieppePAEggerMRisk of cardiovascular events and rofecoxib: cumulative meta-analysisLancet200436494502021202915582059
   PubMed Web of Science ®Google Scholar
• MukherjeeDNissenSETopolEJRisk of cardiovascular events associated with selective COX-2 inhibitorsJAMA2001286895495911509060
   PubMed Web of Science ®Google Scholar
• RostomADubéCLewinGNonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task ForceAnn Intern Med2007146537638917339623
   PubMed Web of Science ®Google Scholar
• SerebruanyVLSteinhublSRBergerPBAnalysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trialsAm J Cardiol200595101218122215877994
   PubMed Web of Science ®Google Scholar
• DubéCRostomALewinGThe use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task ForceAnn Intern Med2007146536537517339622
   PubMed Web of Science ®Google Scholar
• Massó GonzálezELPatrignaniPTacconelliSGarcía RodríguezLAVariability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleedingArthritis Rheum20106261592160120178131
   PubMed Web of Science ®Google Scholar
• Bibbins-DomingoKU.S. Preventive Services Task ForceAspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. preventive services task force recommendation statementAnn Intern Med20161641283684527064677
   PubMed Web of Science ®Google Scholar
• CampbellCLSmythSMontalescotGSteinhublSRAspirin dose for the prevention of cardiovascular disease: a systematic reviewJAMA2007297182018202417488967
   PubMed Web of Science ®Google Scholar
• BonovasSFiorinoGLytrasTMalesciADaneseSCalcium supplementation for the prevention of colorectal adenomas: a systematic review and meta-analysis of randomized controlled trialsWorld J Gastroenterol201622184594460327182169
   PubMedGoogle Scholar
• CarrollCCooperKPapaioannouDHindDPilgrimHTappendenPSupplemental calcium in the chemoprevention of colorectal cancer: a systematic review and meta-analysisClin Ther201032578980320685491
   PubMed Web of Science ®Google Scholar
• ShaukatAScourasNSchünemannHJRole of supplemental calcium in the recurrence of colorectal adenomas: a metaanalysis of randomized controlled trialsAm J Gastroenterol2005100239039415667497
   PubMedGoogle Scholar
• CooperKSquiresHCarrollCChemoprevention of colorectal cancer: systematic review and economic evaluationHealth Technol Assess201014321206
   Web of Science ®Google Scholar
• GuptaSSussmanDADoubeniCAChallenges and possible solutions to colorectal cancer screening for the underservedJ Natl Cancer Inst20141064dju03224681602
   PubMedGoogle Scholar
• SteinwachsDAllenJDBarlowWENIH state-of-the-science conference statement: enhancing use and quality of colorectal cancer screeningNIH Consens State Sci Statements2010271131
   PubMedGoogle Scholar
• Centers for Medicare and Medicaid Services, Office of the Actuary, National Health Statistics Group [webpage on the Internet]National Health Expenditure Data2012 Available from: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/index.htmlAccessed December 15, 2016
   Google Scholar
• VeettilSKChaiyakunaprukNSaokaewSGheeLKMooiCSComparative Effectiveness of Chemopreventive Interventions for Colorectal Cancer: Protocol for a Systematic Review and Network Meta-analysis PROSPERO 2015; CRD420150258492015 Available from: http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015025849Accessed December 15, 2016
   Google Scholar
• VeettilSKSaokaewSLimKGChingSMPhisalprapaPChaiyakunaprukNComparative effectiveness of chemopreventive interventions for colorectal cancer: protocol for a systematic review and network meta-analysis of randomised controlled trialsJ Gastrointest Oncol20167459560227563450
   PubMedGoogle Scholar
• MoherDLiberatiATetzlaffJAltmanDGPRISMA GroupPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementAnn Intern Med20091514264269W6419622511
   PubMed Web of Science ®Google Scholar
• AsanoTKMcLeodRSNon steroidal anti-inflammatory drugs (NSAID) and Aspirin for preventing colorectal adenomas and carcinomasCochrane Database Syst Rev20042CD004079
   Google Scholar
• BaronJAEpidemiology of non-steroidal anti-inflammatory drugs and cancerProg Exp Tumor Res20033712412795046
   PubMed Web of Science ®Google Scholar
• ColeBFLoganRFHalabiSAspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trialsJ Natl Cancer Inst2009101425626619211452
   PubMedGoogle Scholar
• GaoFLiaoCLiuLTanACaoYMoZThe effect of aspirin in the recurrence of colorectal adenomas: a meta-analysis of randomized controlled trialsColorectal Dis200911989390119055515
   PubMedGoogle Scholar
• BjelakovicGNagorniANikolovaDSimonettiRGBjelakovicMGluudCMeta-analysis: antioxidant supplements for primary and secondary prevention of colorectal adenomaAliment Pharmacol Ther200624228129116842454
   PubMed Web of Science ®Google Scholar
• HigginsJPTAltmanDGGøtzschePCThe Cochrane Collaboration’s tool for assessing risk of bias in randomised trialsBMJ2011343d592822008217
   PubMed Web of Science ®Google Scholar
• HigginsJPTGreenS webpage on the InternetCochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. [Updated March 2011]The Cochrane Collaboration2011 Available from: http://handbook.cochrane.org/Accessed December 15, 2016
   Google Scholar
• AtkinsDBestDBrissPAGrading quality of evidence and strength of recommendationsBMJ20043287454149015205295
   PubMed Web of Science ®Google Scholar
• GuyattGHOxmanADVistGEGRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ2008336765092492618436948
   PubMed Web of Science ®Google Scholar
• PuhanMASchünemannHJMuradMHA GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysisBMJ2014349g563025252733
   PubMed Web of Science ®Google Scholar
• HoaglinDCHawkinsNJansenJPConducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2Value Health201114442943721669367
   PubMed Web of Science ®Google Scholar
• VeronikiAAVasiliadisHSHigginsJPTSalantiGEvaluation of inconsistency in networks of interventionsInt J Epidemiol201342133234523508418
   PubMedGoogle Scholar
• BucherHCGuyattGHGriffithLEWalterSDThe results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trialsJ Clin Epidemiol19975066836919250266
   PubMed Web of Science ®Google Scholar
• SalantiGAdesAEIoannidisJPAGraphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorialJ Clin Epidemiol201164216317120688472
   PubMed Web of Science ®Google Scholar
• MillsEJKantersSThorlundKChaimaniAVeronikiA-AIoannidisJPAThe effects of excluding treatments from network meta-analyses: surveyBMJ2013347f519524009242
   PubMedGoogle Scholar
• RoncucciLDi DonatoPCaratiLAntioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Colorectal Cancer Study Group of the University of Modena and the Health Care District 16Dis Colon Rectum19933632272348449125
   PubMed Web of Science ®Google Scholar
• PommergaardH-CBurcharthJRosenbergJRaskovHAspirin, calcitriol, and calcium do not prevent adenoma recurrence in a randomized controlled trialGastroenterology2016150111412226404953
   PubMedGoogle Scholar
• GrauMVSandlerRSMcKeown-EyssenGNonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized studyJ Natl Cancer Inst2009101426727619211442
   PubMedGoogle Scholar
• ArberNSpicakJRáczIFive-year analysis of the prevention of colorectal sporadic adenomatous polyps trialAm J Gastroenterol201110661135114621503000
   PubMed Web of Science ®Google Scholar
• BaronJABeachMMandelJSCalcium supplements and colorectal adenomas. Polyp Prevention Study GroupAnn N Y Acad Sci199988913814510668490
   PubMedGoogle Scholar
• BertagnolliMMEagleCJZauberAGFive-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib TrialCancer Prev Res (Phila)20092431032119336730
   PubMed Web of Science ®Google Scholar
• PalmieriYReduction of the Incidence of Metachronous Adenomas of the Large Bowel by Means of AntioxidantsBrusselsSe-Te Press1998
   Google Scholar
• LiZYGuJLZengZShiWClinical study of aspirin in the prevention of recurrence of colorectal adenoma in the elderlyChinese J Med Guide20111389
   Google Scholar
• BenamouzigRUzzanBDeyraJMartinAChaussadeSPrevention by aspirin of colorectal adenoma recurrence: some advances and latest results of the APACC trialCurr Colorectal Cancer Rep2010713341
   Google Scholar
• JaszewskiRMisraSTobiMFolic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trialWorld J Gastroenterol200814284492449818680228
   PubMedGoogle Scholar
• Bonithon-KoppCKronborgOGiacosaARäthUFaivreJCalcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study GroupLancet200035692381300130611073017
   PubMed Web of Science ®Google Scholar
• Castillo-LancellottiCTur MaríJAUauy DagachRSuplementación con ácido fólico y prevención de recurrencia de adenomas colorrectales; revisión sistemática [Folic acid supplementation and colorectal adenoma recurrence: systematic review]Nutr Hosp20122711321 Spanish22566300
   PubMedGoogle Scholar
• OfmanJJMacleanCHStrausWLMeta-analysis of dyspepsia and nonsteroidal antiinflammatory drugsArthritis Rheum200349450851812910557
   PubMed Web of Science ®Google Scholar
• OfmanJJMacLeanCHStrausWLA metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugsJ Rheumatol200229480481211950025
   PubMed Web of Science ®Google Scholar
• CaldwellBAldingtonSWeatherallMShirtcliffePBeasleyRRisk of cardiovascular events and celecoxib: a systematic review and meta-analysisJ R Soc Med200699313214016508052
   PubMed Web of Science ®Google Scholar
• ZhangJDingELSongYAdverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trialsJAMA2006296131619163216968832
   PubMed Web of Science ®Google Scholar
• TaiVLeungWGreyAReidIRBollandMJCalcium intake and bone mineral density: systematic review and meta-analysisBMJ2015351h418326420598
   PubMed Web of Science ®Google Scholar
• BollandMJLeungWTaiVCalcium intake and risk of fracture: systematic reviewBMJ2015351h458026420387
   PubMed Web of Science ®Google Scholar
• TangBMPEslickGDNowsonCSmithCBensoussanAUse of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysisLancet2007370958865766617720017
   PubMed Web of Science ®Google Scholar
• BollandMJAvenellABaronJAEffect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysisBMJ2010341c369120671013
   PubMed Web of Science ®Google Scholar
• BollandMJGreyAAvenellAGambleGDReidIRCalcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysisBMJ2011342d204021505219
   PubMed Web of Science ®Google Scholar
• Antithrombotic Trialists’ CollaborationCollaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ20023247329718611786451
   PubMed Web of Science ®Google Scholar